vaccine research

Cytophage Technologies Ltd. develops tailor-made bacteriophages as a sustainable solution to bacterial infection and disease. Using proprietary technology, the company produces targeted bacteria-killing phages in weeks to months, which complement and reduce the need for antibiotics. Applications span food safety, animal health (starting with poultry and swine), and human health, plus research on a phage nasal spray against SARS-CoV-2.

bacteriophage productiongenetic engineering of phagesphage therapy research

A small one-man laboratory continuing the themes of Fuller Laboratories, which was sold to VMRD after 35 years of diagnostic work with vector-borne agents. The lab operates a small Class 2 facility focused on cell culture and microscopy, and uses IFA, ELISA and western immuno-blot techniques. Its initial vaccine focus uses common but non-pathogenic Rickettsia spp. to attempt immunization against all species, and it collaborates with university research laboratories for agents such as Babesia microti and Theileria orientalis Ikeda.

cell cultureELISAIFAMicroscopywestern immuno-blot

K2 Medical Research is a privately-owned clinical research organization with facilities in Florida, Tennessee, and Rhode Island and headquarters in Orlando, Florida. It specializes in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of participants.

biomarker researchclinical researchdiagnostics researchmultiphasic clinical trialstranslational research

Kentucky Pediatric Research, Inc. (doing business as Kentucky Pediatric/Adult Research) has been participating in pharmaceutical sponsored clinical trials since 1986 and has conducted approximately 600 Phase I-IV trials in a wide range of therapeutic areas, specializing in vaccines and anti-infectives. It is a dedicated outpatient research department within a large rural pediatric practice, Physicians to Children & Adolescents, PSC, in Bardstown, KY.

anti-infective researchclinical trialsPhase I-IV trials